1. Home
  2. BMRA vs ARTL Comparison

BMRA vs ARTL Comparison

Compare BMRA & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • ARTL
  • Stock Information
  • Founded
  • BMRA 1971
  • ARTL 2011
  • Country
  • BMRA United States
  • ARTL United States
  • Employees
  • BMRA N/A
  • ARTL N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMRA Health Care
  • ARTL Health Care
  • Exchange
  • BMRA Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • BMRA 8.2M
  • ARTL 6.7M
  • IPO Year
  • BMRA N/A
  • ARTL N/A
  • Fundamental
  • Price
  • BMRA $2.96
  • ARTL $3.38
  • Analyst Decision
  • BMRA
  • ARTL Buy
  • Analyst Count
  • BMRA 0
  • ARTL 2
  • Target Price
  • BMRA N/A
  • ARTL $30.00
  • AVG Volume (30 Days)
  • BMRA 250.1K
  • ARTL 74.1K
  • Earning Date
  • BMRA 10-14-2025
  • ARTL 11-11-2025
  • Dividend Yield
  • BMRA N/A
  • ARTL N/A
  • EPS Growth
  • BMRA N/A
  • ARTL N/A
  • EPS
  • BMRA N/A
  • ARTL N/A
  • Revenue
  • BMRA $4,884,000.00
  • ARTL N/A
  • Revenue This Year
  • BMRA N/A
  • ARTL N/A
  • Revenue Next Year
  • BMRA N/A
  • ARTL N/A
  • P/E Ratio
  • BMRA N/A
  • ARTL N/A
  • Revenue Growth
  • BMRA N/A
  • ARTL N/A
  • 52 Week Low
  • BMRA $2.08
  • ARTL $3.15
  • 52 Week High
  • BMRA $10.16
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 50.63
  • ARTL 28.70
  • Support Level
  • BMRA $2.82
  • ARTL $3.15
  • Resistance Level
  • BMRA $3.19
  • ARTL $3.61
  • Average True Range (ATR)
  • BMRA 0.20
  • ARTL 0.36
  • MACD
  • BMRA 0.02
  • ARTL 0.02
  • Stochastic Oscillator
  • BMRA 56.53
  • ARTL 14.29

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: